Breaking News

Centene settles another PBM probe; a sizable shift for federally funded research

 

Pharmalot Ed Silverman

STAT+: Centene agrees to pay $33 million to resolve another state probe into its pharmacy benefits business

By Ed Silverman

Adobe

This is the 10th settlement that Centene has reached with a state government over inaccurate reporting of pharmacy benefits services.

Read More

STAT+: Pfizer's experimental RSV vaccine protects older adults in study

By Matthew Herper

Mark Lennihan/AP

The company said Thursday the vaccine reduced the risk for older adults of respiratory syncytial virus, or RSV.

Read More

White House directs agencies to make federally funded studies free to access

By Sarah Owermohle

APStock

The guidance from the White House's Office of Science and Technology Policy effectively ushers in a sea change in the publishing industry.

Read More

Fauci's non-retirement, grading biotech VCs, & a bellwether IPO

By Damian Garde and Allison DeAngelis

Our colleague Helen Branswell joins to explain the Covid-19 booster debate and the long career of the soon-to-step-down Anthony Fauci.

Read More

STAT+: Why Amazon and other corporate giants are in a bidding war for home health technology

By Casey Ross and Katie Palmer

Adobe

Signify Health, which provides home health care, could fetch multibillion dollar offers from Amazon, CVS, and United.

Read More

Thursday, August 25, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments